Heffernan Michael Thomas
- SEC CIK
- 0001448914
In the past year, 1 open-market sale filing worth $595.8K and no purchases.
Current role at each company
- TRVI Trevi Therapeutics, Inc.Directoras of Sep 17, 2026
- ENGN enGene Therapeutics Inc.Directoras of Jun 17, 2026
- AVTX Avalo Therapeutics, Inc.Directoras of Jun 4, 2026
- BHVN Biohaven Ltd.Directoras of Apr 30, 2026
- COLL Collegium Pharmaceutical, IncDirectoras of Feb 12, 2025
Show 2 more companies
- SYBX Synlogic, Inc.Directoras of Jun 26, 2023
- Biohaven Pharmaceutical Holding Co Ltd.Directoras of Oct 3, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $595.8K
- 1 filing
- Net
- −$595.8K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Heffernan Michael Thomas as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
TRVI Trevi Therapeutics, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 17, 2026 (view filing)4:55 PM ET | Sep 15 | 2 days | Heffernan Michael ThomasDirector | SSale | −39.5K | $15.09 | −$595.8K | −86.1%6.35K after | 4 lots10b5-1 |
COLL Collegium Pharmaceutical, Inc
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 27, 2022 (view filing) | Dec 22-27 | 5 days | Heffernan Michael ThomasDirector | SSale | −25.0K | $23.58 | −$590.5K | −47.2%28.0K after | 4 lots |
| Dec 21, 2022 (view filing) | Dec 19-21 | 2 days | Heffernan Michael ThomasDirector | SSale | −84.0K | $23.09 | −$1.94M | −75.0%28.0K after | 3 lots |
| Dec 14, 2022 (view filing) | Dec 12-13 | 2 days | Heffernan Michael ThomasDirector | SSale | −189.6K | $22.14 | −$4.20M | −87.1%28.0K after | 2 lots |